Will waiving patents for covid-19 vaccines boost global supplies?

Share with us

Health | Analysis 10 May 2021 , updated 10 May 2021 By Adam Vaughan A medical worker transfers a dose of covid-19 vaccine at the Makati Coliseum in the PhilippinesCredit: Majority World/Shutterstock“These extraordinary times and circumstances… call for extraordinary measures,” tweeted US trade representative Katherine Tai, as she surprised the world by throwing the country’s…

Will waiving patents for covid-19 vaccines boost global supplies?
Share with us


Health


| Analysis

10 May 2021
, updated 10 May 2021

By Adam Vaughan

A medical worker transfers a dose of covid-19 vaccine at the Makati Coliseum in the Philippines

A medical worker transfers a dose of covid-19 vaccine at the Makati Coliseum in the Philippines

Credit: Majority World/Shutterstock

“These extraordinary times and circumstances… call for extraordinary measures,” tweeted US trade representative Katherine Tai, as she surprised the world by throwing the country’s backing behind a temporary waiver of intellectual property rights for covid-19 vaccines.

The announcement on 5 May turbo-charged an idea pushed by India, South Africa and many campaigners: that lifting the IP protections on covid-19 vaccines would boost supplies by allowing the vaccines to be made in greater numbers, in more countries.

The World Health Organization …

Article amended on
10 May 2021

This article has been updated to include information on the World Health Organization’s C-TAP plan.

 

Read More

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *